Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Benitec Biopharma (BNTC) Leases (2019 - 2025)

Benitec Biopharma has reported Leases over the past 7 years, most recently at $905000.0 for Q4 2025.

  • Quarterly results put Leases at $905000.0 for Q4 2025, up 560.58% from a year ago — trailing twelve months through Dec 2025 was $905000.0 (up 560.58% YoY), and the annual figure for FY2025 was $860000.0, up 218.52%.
  • Leases reached $905000.0 in Q4 2025 per BNTC's latest filing, up from $755000.0 in the prior quarter.
  • Across five years, Leases topped out at $964000.0 in Q1 2025 and bottomed at $137000.0 in Q4 2024.
  • Median Leases over the past 5 years was $680500.0 (2022), compared with a mean of $611300.0.
  • The largest annual shift saw Leases plummeted 65.75% in 2024 before it skyrocketed 560.58% in 2025.
  • Over 5 years, Leases stood at $888000.0 in 2021, then dropped by 26.8% to $650000.0 in 2022, then tumbled by 38.46% to $400000.0 in 2023, then tumbled by 65.75% to $137000.0 in 2024, then surged by 560.58% to $905000.0 in 2025.
  • Business Quant data shows Leases for BNTC at $905000.0 in Q4 2025, $755000.0 in Q3 2025, and $860000.0 in Q2 2025.